NSW Clinical Trials Business Development Centre   Overview The NSW Clinical Trials Business Development Centre acts as a point of contact for sponsors wanting to conduct studies in Australia. Through the establishment of networks across major therapeutic areas the Centre will be able to assist in the placement of studies for the pharmaceutical, biotechnology and medical devices sectors. The Centre is also committed to working with NSW trialists in developing and implementing strategies to promote efficiencies in trial management and to increase the rates of patient recruitment to facilitate the successful conduct of trials in NSW. Business Opportunities (i.e Corporate Alliances/Partnerships) The NSW Clinical Trials Business Development Centre is seeking to establish strong networks with the pharmaceutical, biotechnology and medical devices sectors in order to promote Australia’s and NSW clinical research strengths and capabilities. We aim to identify and establish partnerships with sponsors from Japan, China, India as well as the US and European Union. The ideal distribution model is for companies interested in conducting clinical trials in Australia to initiate contact with the Centre to expedite the placement and start-up activities of clinical trials. Technology/Products and Services Description To facilitate and improve capacity, quality and timelines of clinical trials the NSW Clinical Trials Business Development Centre provides the following services: Point of contact for industry sponsors to facilitate clinical trial placement in NSW. Provision of information to stakeholders on trial activity in NSW including information on infrastructure, clinical strengths, costs and opportunities. Facilitation in the development of functional cooperative networks in specific therapeutic areas to enable future trial partnerships. Development and implementation of strategies to promote efficiencies in trial management. Competitive Advantages With its prime location in the Asia Pacific region, NSW competitive advantages for conducting clinical trials include: Strong research community (6 of the top 50 rated universities in biomedicine were Australian, including both the university of Sydney and University of NSW). Single ethics review for multi-centre clinical trials. The regulatory clinical trial notification (CTN) scheme allows for one of the fastest regulatory approval times globally. Treatment and regulatory standards that meet US and European requirements. Large ethnically diverse population, satisfying demographic needs of any clinical trial. Stable political environment. Strong intellectual property laws. Well developed infrastructure for the conduct of clinical trials. Proximity and established links to Asia-Pacific. Website address: www.clinicaltrials.org.au